NantHealth, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 67 million compared to USD 62.65 million a year ago. Net loss was USD 67.78 million compared to USD 58.26 million a year ago.

Basic loss per share from continuing operations was USD 8.8 compared to USD 7.66 a year ago. Diluted loss per share from continuing operations was USD 8.8 compared to USD 7.66 a year ago. Basic loss per share was USD 8.8 compared to USD 7.66 a year ago.

Diluted loss per share was USD 8.8 compared to USD 7.66 a year ago.